Sarepta’s Medical Director, Clinical Development discusses the company’s upcoming ENVISION study for SRP-9001. Research & Clinical Trial Webinars, Webinars Posted on June 16, 2023 FacebookTwitterLinkedinPin ItWhatsApp You may also like 1:00:42 AGAMREE® Approval with Catalyst Pharmaceuticals, Inc. Posted on December 1, 2023 Care Webinars, Webinars agamree, catalyst, vamorolone 59:54 Overview of Topline Results from Phase 3 EMBARK Study Posted on November 13, 2023 Research & Clinical Trial Webinars, Webinars sarepta 50:51 AGAMREE Approval: What this means for you and your family Posted on November 6, 2023 Care Webinars, Webinars 25:01 Advocating for Access: Overview of Medicaid DUR and P&T Meetings Posted on October 31, 2023 Care Webinars, Webinars feature, insurance, medicaid 54:28 Capricor Therapeutics: CAP-1002 HOPE-3 Program Update Posted on October 30, 2023 Research & Clinical Trial Webinars, Webinars capricor 49:31 Edgewise Therapeutics: A Novel Approach Designed to Protect Muscle in Becker Muscular Dystrophy Posted on October 24, 2023 Research & Clinical Trial Webinars, Webinars edg-5506, edgewise 59:38 Supporting Families Through Decision Making Posted on October 17, 2023 Care Webinars, Webinars palliative care 52:31 Affinity Duchenne™ and Affinity Beyond™: Updates on Investigational RGX-202 from REGENXBIO Posted on October 13, 2023 Research & Clinical Trial Webinars, Webinars 123…23»Page 1 of 23